Jason E. Kemner

624 total citations
21 papers, 495 citations indexed

About

Jason E. Kemner is a scholar working on Psychiatry and Mental health, Molecular Biology and Pathology and Forensic Medicine. According to data from OpenAlex, Jason E. Kemner has authored 21 papers receiving a total of 495 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Psychiatry and Mental health, 5 papers in Molecular Biology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Jason E. Kemner's work include Attention Deficit Hyperactivity Disorder (6 papers), Spine and Intervertebral Disc Pathology (5 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers). Jason E. Kemner is often cited by papers focused on Attention Deficit Hyperactivity Disorder (6 papers), Spine and Intervertebral Disc Pathology (5 papers) and Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers). Jason E. Kemner collaborates with scholars based in United States, France and Belarus. Jason E. Kemner's co-authors include H. Lynn Starr, Mark Olfson, George J. Wan, Steven C. Marcus, Maureen J. Lage, Patrick E. Ciccone, Kent H. Summers, Scott D. Ramsey, Howard G. Birnbaum and Stephanie A. Leong and has published in prestigious journals such as Circulation, Diabetes Care and Vaccine.

In The Last Decade

Jason E. Kemner

19 papers receiving 448 citations

Peers

Jason E. Kemner
Michael A Boyle Ireland
Angelia Mosley‐Williams United States
Michele Polfuss United States
Jane Christie United Kingdom
Donna Spencer United States
Neha Godiwala United States
Karl S. Bagraith Australia
Ann R. Poindexter United States
John C. Friel United States
Dragana Ignjatović Ristić Serbia
Michael A Boyle Ireland
Jason E. Kemner
Citations per year, relative to Jason E. Kemner Jason E. Kemner (= 1×) peers Michael A Boyle

Countries citing papers authored by Jason E. Kemner

Since Specialization
Citations

This map shows the geographic impact of Jason E. Kemner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jason E. Kemner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jason E. Kemner more than expected).

Fields of papers citing papers by Jason E. Kemner

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jason E. Kemner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jason E. Kemner. The network helps show where Jason E. Kemner may publish in the future.

Co-authorship network of co-authors of Jason E. Kemner

This figure shows the co-authorship network connecting the top 25 collaborators of Jason E. Kemner. A scholar is included among the top collaborators of Jason E. Kemner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jason E. Kemner. Jason E. Kemner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Bhambri, Rahul, Marianna Bruno, Yong Chen, et al.. (2023). Real-World Characteristics of Patients with Wild-Type Transthyretin Amyloid Cardiomyopathy: An Analysis of Electronic Healthcare Records in the United States. American Journal of Cardiovascular Drugs. 23(2). 197–206. 5 indexed citations
3.
Roy, Anuja, Andrew M. Peterson, José Alvir, et al.. (2022). Baseline Characteristics and Secondary Medication Adherence Patterns Among Patients Receiving Tafamidis Prescriptions: A Retrospective Analysis Using a National Specialty Pharmacy Dispensing Database. Patient Preference and Adherence. Volume 16. 1115–1129. 4 indexed citations
4.
Kemner, Jason E., Mark H. Rozenbaum, Yong Chen, et al.. (2022). Abstract 10136: Tafamidis Patient Characteristics and Adherence: A Retrospective Analysis of German Statutory Health Insurance Data. Circulation. 146(Suppl_1). 1 indexed citations
5.
6.
Ong, Kevin, Edmund Lau, Jason E. Kemner, & Steven M. Kurtz. (2012). Two-year cost comparison of vertebroplasty and kyphoplasty for the treatment of vertebral compression fractures: are initial surgical costs misleading?. Osteoporosis International. 24(4). 1437–1445. 20 indexed citations
7.
8.
Edidin, Avram A., Kevin Ong, Edmund Lau, et al.. (2012). Cost-Effectiveness Analysis of Treatments for Vertebral Compression Fractures. Applied Health Economics and Health Policy. 10(4). 273–284. 32 indexed citations
9.
10.
Ong, Kevin, et al.. (2012). Cost-Effectiveness Analysis of Treatments for Vertebral Compression Fractures. The Spine Journal. 12(9). S13–S13. 2 indexed citations
11.
Stuart, Bruce, et al.. (2010). Does influenza vaccination of older adult Medicare beneficiaries lower treatment costs for acute and chronic respiratory disease?. ˜The œAmerican journal of geriatric pharmacotherapy. 8(3). 201–214. 3 indexed citations
12.
Weycker, Derek, Oleg Sofrygin, Jason E. Kemner, Stephen I. Pelton, & Gerry Oster. (2009). Cost of routine immunization of young children against rotavirus infection with Rotarix versus RotaTeq. Vaccine. 27(36). 4930–4937. 11 indexed citations
13.
Kemner, Jason E. & Maureen J. Lage. (2006). Impact of methylphenidate formulation on treatment patterns and hospitalizations: a retrospective analysis. Annals of General Psychiatry. 5(1). 5–5. 28 indexed citations
14.
Kemner, Jason E. & Maureen J. Lage. (2006). Effect of methylphenidate formulation on treatment patterns and use of emergency room services. American Journal of Health-System Pharmacy. 63(4). 317–322. 22 indexed citations
15.
Leibson, Cynthia L., William J. Barbaresi, Jeanine E. Ransom, et al.. (2006). Emergency Department Use and Costs for Youth With Attention-Deficit/Hyperactivity Disorder: Associations With Stimulant Treatment. Ambulatory Pediatrics. 6(1). 45–53. 22 indexed citations
16.
Kemner, Jason E., et al.. (2005). Outcomes of OROS® methylphenidate compared with atomoxetine in children with ADHD: A multicenter, randomized prospective study. Advances in Therapy. 22(5). 498–512. 82 indexed citations
17.
Marcus, Steven C., George J. Wan, Jason E. Kemner, & Mark Olfson. (2005). Continuity of Methylphenidate Treatment for Attention-Deficit/Hyperactivity Disorder. Archives of Pediatrics and Adolescent Medicine. 159(6). 572–572. 132 indexed citations
18.
Starr, H. Lynn & Jason E. Kemner. (2005). Multicenter, randomized, open-label study of OROS methylphenidate versus atomoxetine: treatment outcomes in African-American children with ADHD.. PubMed. 97(10 Suppl). 11S–16S. 38 indexed citations
19.
Ramsey, Scott D., Kent H. Summers, Stephanie A. Leong, et al.. (2002). Productivity and Medical Costs of Diabetes in a Large Employer Population. Diabetes Care. 25(1). 23–29. 86 indexed citations
20.
Ohsfeldt, Robert L., et al.. (2001). Patterns of physician-reported diagnoses for women receiving raloxifene prescriptions. American Journal of Health-System Pharmacy. 58(19). 1846–1849.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael A Boyle Breakdown of academic impact, for papers by Angelia Mosley‐Williams Breakdown of academic impact, for papers by Michele Polfuss Breakdown of academic impact, for papers by Jane Christie Breakdown of academic impact, for papers by Donna Spencer Breakdown of academic impact, for papers by Neha Godiwala Breakdown of academic impact, for papers by Karl S. Bagraith Breakdown of academic impact, for papers by Ann R. Poindexter Breakdown of academic impact, for papers by John C. Friel Breakdown of academic impact, for papers by Dragana Ignjatović Ristić
Rankless by CCL
2026